Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin nasal irrigation after sinus surgery for chronic rhinosinusitis with bilateral nasal polyps
IRCT20210923052559N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2025
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, double-blind trial of gentamicin in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Clinical symptoms assessed using the SNOT-22 questionnaire. Started May 2025; status: completed.
02
Drugs
gentamicin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20210923052559N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210923052559N4.